Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SOLIGENIX, INC. Director's Dealing 2009

Oct 13, 2009

35119_dirs_2009-10-13_fdee311a-3769-47b9-9046-24d868aa92c2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SOLIGENIX, INC. (SNGX)
CIK: 0000812796
Period of Report: 2009-10-08

Reporting Person: Rubin Robert Joseph (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2009-10-08 Stock Options (right to buy) $.31 A 300000 Acquired 2019-10-07 Common Stock (300000) Direct

Footnotes

F1: As a new Board member, the Company granted Dr. Rubin options to purchase 300,000 shares of the Company's common stock at a strike price of $0.31 with an expiration date of October 7, 2019. All options vested on October 8, 2009.